Search research articles
Contact Us
Filters
Showing results (301-310 of 333) with videos related to
Page
of 34
Sort By:
Journal of Clinical Epidemiology
|
March 24, 2024
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada
Zoë R Greenwald, Dan Werb, Jordan J Feld, et al.
Cancer
|
January 9, 2020
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs
Aaron R Hansen, Kari Ala-Leppilampi, Chris McKillop, et al.
JHEP Reports : Innovation in Hepatology
|
April 8, 2026
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
Nicolaas Van Renne, Fleur Ballet, Stijn Van Hees, et al.
Hepatology Communications
|
February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review
Sofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
JHEP Reports : Innovation in Hepatology
|
October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis
Lesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.
Gut
|
February 12, 2013
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C
Yaron Rotman, Mazen Noureddin, Jordan J Feld, et al.
The New England Journal of Medicine
|
November 17, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Jordan J Feld, Ira M Jacobson, Christophe Hézode, et al.
The International Journal on Drug Policy
|
July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Jason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
The Lancet. Gastroenterology & Hepatology
|
May 12, 2020
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study
Jordan J Feld, Marcelo Cypel, Deepali Kumar, et al.
Hepatology (Baltimore, Md.)
|
November 4, 2025
Technical systematic review supporting 2025 AASLD practice guidelines on management of chronic hepatitis B
Calvin Q Pan, Samer Saadi, Marc G Ghany, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 333) with videos related to
Sort By:
Page
of 34
Journal of Clinical Epidemiology
|
March 24, 2024
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, Canada
Zoë R Greenwald, Dan Werb, Jordan J Feld, et al.
Cancer
|
January 9, 2020
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMs
Aaron R Hansen, Kari Ala-Leppilampi, Chris McKillop, et al.
JHEP Reports : Innovation in Hepatology
|
April 8, 2026
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells
Nicolaas Van Renne, Fleur Ballet, Stijn Van Hees, et al.
Hepatology Communications
|
February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review
Sofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
JHEP Reports : Innovation in Hepatology
|
October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis
Lesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.
Gut
|
February 12, 2013
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C
Yaron Rotman, Mazen Noureddin, Jordan J Feld, et al.
The New England Journal of Medicine
|
November 17, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Jordan J Feld, Ira M Jacobson, Christophe Hézode, et al.
The International Journal on Drug Policy
|
July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Jason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
The Lancet. Gastroenterology & Hepatology
|
May 12, 2020
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study
Jordan J Feld, Marcelo Cypel, Deepali Kumar, et al.
Hepatology (Baltimore, Md.)
|
November 4, 2025
Technical systematic review supporting 2025 AASLD practice guidelines on management of chronic hepatitis B
Calvin Q Pan, Samer Saadi, Marc G Ghany, et al.
Page
of 34